Orion completes acquisition of LegoChem Biosciences

Reporter Kim SangJin / approved : 2024-04-01 03:57:19
  • -
  • +
  • 인쇄

(Photo = Yonhap news)

 

[Alpha Biz=(Chicago) Reporter Paul Lee] Orion said it has become the largest shareholder after paying 548.5 billion won in stock prices to acquire a 25.73% stake in LegoChem Biosciences.

Orion participated in LegoChem Biosciences's third-party paid-in capital increase and was allocated 7,963,283 shares for 59,000 won. It purchased 1.4 million old shares at a base price of 56,186 won from its founder Kim Yong-joo and CEO Park Se-jin to secure a total of 9,363,283 shares.

It plans to develop new drugs through its affiliate LegoChem Biosciences and complete its business portfolio for the group's sustainable growth.

 

 

Alphabiz Reporter Kim SangJin(hoondork1977@alphabiz.co.kr)

어플

주요기사

Eastar Jet Founder Lee Sang-jik Acquitted in Hiring Irregularities Case on Appeal2025.11.06
SK & AWS Ulsan AI Data Center Plan Faces Delay as Ulsan Mipo Industrial Complex Excluded from Korea’s Distributed Energy Special Zone2025.11.06
Seoul High Prosecutors’ Office Launches Search of Ssangbangwool Group Subsidiary Amid Allegations of “Salmon & Soju Party” Witness Bribery in North-Korea Remittance Probe2025.11.06
National Pension Service of Korea to Support Elon Musk’s Compensation Package at Tesla; Opposes AI-Startup Investment Proposal2025.11.06
Hyundai Rotem Refutes Allegations of Supplying Faulty Locomotive Parts to Bangladesh2025.11.06
뉴스댓글 >

건강이 보이는 대표 K Medical 뉴스

HEADLINE

PHOTO

많이 본 기사